As of 2025-09-18, the Relative Valuation of Sana Biotechnology Inc (SANA) is (15.25) USD. This relative valuation is based on P/E multiples. With the latest stock price at 3.04 USD, the upside of Sana Biotechnology Inc based on Relative Valuation is -601.7%.
The range of the Relative Valuation is (14.64) - (15.87) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 14.3x - 15.5x | 14.9x |
| Forward P/E multiples | 14.2x - 15.6x | 14.9x |
| Fair Price | (14.64) - (15.87) | (15.25) |
| Upside | -581.5% - -621.9% | -601.7% |
| Date | P/E |
| 2025-09-15 | -3.16 |
| 2025-09-12 | -3.15 |
| 2025-09-11 | -3.32 |
| 2025-09-10 | -2.84 |
| 2025-09-09 | -2.95 |
| 2025-09-08 | -2.93 |
| 2025-09-05 | -2.89 |
| 2025-09-04 | -2.91 |
| 2025-09-03 | -2.92 |
| 2025-09-02 | -2.77 |
| 2025-08-29 | -2.99 |
| 2025-08-28 | -2.94 |
| 2025-08-27 | -3.29 |
| 2025-08-26 | -3.15 |
| 2025-08-25 | -3.27 |
| 2025-08-22 | -3.50 |
| 2025-08-21 | -3.52 |
| 2025-08-20 | -3.39 |
| 2025-08-19 | -3.38 |
| 2025-08-18 | -3.32 |
| 2025-08-15 | -3.25 |
| 2025-08-14 | -3.35 |
| 2025-08-13 | -3.25 |
| 2025-08-12 | -3.04 |
| 2025-08-11 | -2.85 |
| 2025-08-08 | -2.93 |
| 2025-08-07 | -2.90 |
| 2025-08-06 | -4.15 |
| 2025-08-05 | -4.16 |
| 2025-08-04 | -4.13 |
| 2025-08-01 | -3.82 |
| 2025-07-31 | -3.97 |
| 2025-07-30 | -4.26 |
| 2025-07-29 | -4.35 |
| 2025-07-28 | -4.77 |
| 2025-07-25 | -4.84 |
| 2025-07-24 | -5.01 |
| 2025-07-23 | -5.02 |
| 2025-07-22 | -4.76 |
| 2025-07-21 | -4.34 |
| 2025-07-18 | -4.52 |
| 2025-07-17 | -4.35 |
| 2025-07-16 | -4.23 |
| 2025-07-15 | -4.08 |
| 2025-07-14 | -4.12 |
| 2025-07-11 | -4.08 |
| 2025-07-10 | -3.97 |
| 2025-07-09 | -3.96 |
| 2025-07-08 | -3.80 |
| 2025-07-07 | -3.03 |